These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 479629)

  • 1. Accumulation of urinary cancer-related glycoprotein, EDCl, in psoriasis.
    Fine RM; Chawla RK; Kutner M; Rudman D
    J Invest Dermatol; 1979 Oct; 73(4):264-5. PubMed ID: 479629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of the cancer-related glycoprotein EDCl: effect of chemotherapy.
    Rudman D; Chawla RK; Heymsfield SB; Bethel RA; Shoji M; Vogler R; Nixon DW
    Ann Intern Med; 1977 Feb; 86(2):174-9. PubMed ID: 835938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cancer-related protein EDC1 and serum inter-alpha trypsin inhibitor in breast cancer.
    Chawla RK; Miller FW; Lawson DH; Nixon DW
    Tumour Biol; 1984; 5(6):351-63. PubMed ID: 6085600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of novel glycoprotein HNC1beta from the urine of a patient with acute monocytic leukemia.
    Rudman D; Chawla RK; Nixon DW; Roler JH; Shah VR
    Cancer Res; 1978 Mar; 38(3):602-7. PubMed ID: 272227
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiprotease activity in urine of patients with inflammatory skin disorders.
    Streit V; Wiedow O; Bartels J; Christophers E
    J Invest Dermatol; 1995 Oct; 105(4):562-6. PubMed ID: 7561159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A system of cancer-related urinary glycoproteins: biochemical properties and clinical applications.
    Rudman D; Chawla RK; Wadsworth AD; Nixon DW; Schwartz M
    Trans Assoc Am Physicians; 1977; 90():286-99. PubMed ID: 77073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific proteinuria of cancer patients.
    Rudman D; Chawla RK; Nixon DW
    Trans Assoc Am Physicians; 1978; 91():229-41. PubMed ID: 754392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of plasma inter-alpha trypsin inhibitor and cancer-related glycoprotein EDC1 on phytohemagglutinin-induced thymidine uptake in lymphocytes.
    Chawla RK; Lawson DH; Richmond A; Rudman D
    Cancer Res; 1980 Nov; 40(11):4187-91. PubMed ID: 6162547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related urinary proteinase inhibitor, EDC1: a new method for its isolation and evidence for multiple forms.
    Chawla RK; Lawson DH; Ahmad M; Travis J
    J Cell Biochem; 1992 Nov; 50(3):227-36. PubMed ID: 1469060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The level of urinary epidermal growth factor is not influenced by the extent of psoriatic lesions.
    Kondo S; Sato N; Aso K
    Arch Dermatol Res; 1991; 283(8):516-8. PubMed ID: 1785943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma inter-alpha-trypsin inhibitor-related urinary glycoprotein EDC1 inhibits the growth of a Burkitt's lymphoma cell line.
    Chawla RK; Lawson DH; Travis J
    J Cell Biochem; 1990 Apr; 42(4):207-17. PubMed ID: 1692840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urine neopterin levels in psoriasis.
    Harland CC; Whitaker RP; Barron JL; Holden CA
    Br J Dermatol; 1992 Nov; 127(5):453-7. PubMed ID: 1467282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of skin-derived antileukoproteinase (SKALP) in urine of psoriatic patients.
    Alkemade H; van de Kerkhof P; Schalkwijk J
    J Invest Dermatol; 1992 Jul; 99(1):3-7. PubMed ID: 1607676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunological quantitation of urinary trypsin inhibitor.
    Usui T; Maehara S; Kawashita E; Ishibe T; Sumi H; Toki N
    Enzyme; 1984; 31(1):11-6. PubMed ID: 6714195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
    Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
    J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.
    Alkemade HA; de Jongh GJ; Arnold WP; van de Kerkhof PC; Schalkwijk J
    J Invest Dermatol; 1995 Feb; 104(2):189-93. PubMed ID: 7829874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of urinary trypsin inhibitor in urine, plasma and cancer tissues of patients with stomach cancer.
    Nishino N; Aoki K; Tokura Y; Sakaguchi S; Fujie M; Sugawara Y; Takada Y; Takada A
    Haemostasis; 1989; 19(2):112-9. PubMed ID: 2471673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydroxyproline excretion in psoriasis and psoriatic arthritis].
    Hein G; Knopf B; Barta U; Müller A; Wessel G
    Z Hautkr; 1990 Sep; 65(9):824-6. PubMed ID: 2264373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of growth hormone in plasma of psoriatic arthritis, psoriasis vulgaris and seronegative spondylarthritis].
    Partsch G; Schwarzer C; Dunky A; Mayer F; Gschnait F; Neumüller J; Eberl R
    Z Rheumatol; 1985; 44(6):267-9. PubMed ID: 2869626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of the glycoprotein (JBB5) in the urine of a patient with carcinoma of the colon.
    Chawla RK; Heymsfield SB; Wadsworth AA; Shoji M; Rudman D
    Cancer Res; 1977 Mar; 37(3):873-8. PubMed ID: 402209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.